-
Press Release
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
-
Story
Visualizing molecular glues -
Story
Turning the power of nuclear technology into a medical force -
Story
Tuning drugs to succeed on the cell’s surface -
Story
Rediscovering the power of nature’s exquisite complexity -
Story
Countering the genome reprogramming of cancer cells -
Story
Bringing virtual reality to the lab -
Story
Leveraging the liver’s ability to heal scarred tissue